Hering-Smith Kathleen S, Mao Weibo, Schiro Faith R, Coleman-Barnett Joycelynn, Pajor Ana M, Hamm L Lee
Research Service, Southeastern Louisiana Veterans Health Care System (SLVHCS), New Orleans, LA, 70161, USA,
Urolithiasis. 2014 Jun;42(3):209-19. doi: 10.1007/s00240-014-0653-4. Epub 2014 Mar 21.
Urinary citrate is an important inhibitor of calcium-stone formation. Most of the citrate reabsorption in the proximal tubule is thought to occur via a dicarboxylate transporter NaDC1 located in the apical membrane. OK cells, an established opossum kidney proximal tubule cell line, transport citrate but the characteristics change with extracellular calcium such that low calcium solutions stimulate total citrate transport as well as increase the apparent affinity for transport. The present studies address several fundamental properties of this novel process: the polarity of the transport process, the location of the calcium-sensitivity and whether NaDC1 is present in OK cells. OK cells grown on permeable supports exhibited apical >basolateral citrate transport. Apical transport of both citrate and succinate was sensitive to extracellular calcium whereas basolateral transport was not. Apical calcium, rather than basolateral, was the predominant determinant of changes in transport. Also 2,3-dimethylsuccinate, previously identified as an inhibitor of basolateral dicarboxylate transport, inhibited apical citrate uptake. Although the calcium-sensitive transport process in OK cells is functionally not typical NaDC1, NaDC1 is present in OK cells by Western blot and PCR. By immunolocalization studies, NaDC1 was predominantly located in discrete apical membrane or subapical areas. However, by biotinylation, apical NaDC1 decreases in the apical membrane with lowering calcium. In sum, OK cells express a calcium-sensitive/regulated dicarboxylate process at the apical membrane which responds to variations in apical calcium. Despite the functional differences of this process compared to NaDC1, NaDC1 is present in these cells, but predominantly in subapical vesicles.
尿枸橼酸盐是钙结石形成的重要抑制剂。近端小管中大部分枸橼酸盐重吸收被认为是通过位于顶端膜的二羧酸转运体NaDC1进行的。OK细胞是一种已建立的负鼠肾近端小管细胞系,可转运枸橼酸盐,但其特性会随细胞外钙浓度变化,低钙溶液会刺激总枸橼酸盐转运并增加转运的表观亲和力。本研究探讨了这一新型过程的几个基本特性:转运过程的极性、钙敏感性的位置以及OK细胞中是否存在NaDC1。在可渗透支持物上生长的OK细胞表现出顶端>基底外侧的枸橼酸盐转运。枸橼酸盐和琥珀酸盐的顶端转运对细胞外钙敏感,而基底外侧转运则不敏感。顶端钙而非基底外侧钙是转运变化的主要决定因素。此外,先前被鉴定为基底外侧二羧酸转运抑制剂的2,3 - 二甲基琥珀酸盐可抑制顶端枸橼酸盐摄取。尽管OK细胞中钙敏感的转运过程在功能上并非典型的NaDC1,但通过蛋白质印迹法和聚合酶链反应可知OK细胞中存在NaDC1。通过免疫定位研究,NaDC1主要位于离散的顶端膜或顶端下区域。然而,通过生物素化法检测,随着钙浓度降低,顶端膜中的顶端NaDC1减少。总之,OK细胞在顶端膜表达一种对顶端钙变化有反应的钙敏感/受调控的二羧酸转运过程。尽管该过程与NaDC1在功能上存在差异,但NaDC1存在于这些细胞中,不过主要存在于顶端下囊泡中。